2′-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway

European Journal of Pharmacology

Volumn 696, Issue 1-3, 2012, Pages 179-186

  Kwon, Jung Yeon ^a   Hong, Su Hyung ^b   Park, Sun Dong ^a   Ahn, Sang Gun ^c   Yoon, Jung Hoon ^c   Kwon, Byoung Mog ^d   Kim, Soo A ^a  

^a Dongguk University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Wonkwang University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

2 benzoyloxycinnamaldehyde; AP 1; Atherosclerosis; Cinnamaldehyde; Lipopolysaccharide; Nitric oxide

Indexed keywords

2' BENZOYLOXYCINNAMALDEHYDE; 2' HYDROXYCINNAMALDEHYDE; CINNAMALDEHYDE; CINNAMALDEHYDE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; 2'-BENZOYLOXYCINNAMALDEHYDE; ACROLEIN; ANTIINFLAMMATORY AGENT; BENZOIC ACID DERIVATIVE; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRITE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; IN VIVO STUDY; INOS GENE; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TOXICITY TESTING; TRANSCRIPTION INITIATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG ANTAGONISM; INFLAMMATION; METABOLISM;

ACROLEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOATES; CELL LINE; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; TRANSCRIPTION FACTOR AP-1;

EID: 84869082440     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.09.027     Document Type: Article

References (33)

1. E.D. Chan, and D.W. Riches IFN-gamma+LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line Am. J. Physiol. Cell Physiol. 280 2001 C441 C450
2. L.K. Chao, K.F. Hua, H.Y. Hsu, S.S. Cheng, I.F. Lin, C.J. Chen, S.T. Chen, and S.T. Chang Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling Food Chem. Toxicol. 46 2008 220 231 (Pubitemid 350235768)
3. S.S. Cheng, J.Y. Liu, E.H. Chang, and S.T. Chang Antifungal activity of cinnamaldehyde and eugenol congeners against wood-rot fungi Bioresource Technol. 99 2008 5145 5149
4. J.W. Coleman Nitric oxide in immunity and inflammation Int. Immunopharmacol. 1 2001 1397 1406 (Pubitemid 32622786)
5. B. Dérijard, M. Hibi, I.H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R.J. Davis JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 76 1994 1025 1037 (Pubitemid 24106383)
6. J. Fan, and T. Watanabe Inflammatory reactions in the pathogenesis of atherosclerosis J. Atheroscler. Thromb. 10 2003 63 71
7. D.C. Han, M.Y. Lee, K.D. Shin, S.B. Jeon, J.M. Kim, K.H. Son, H.C. Kim, H.M. Kim, and B.M. Kwon 2′-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species J. Biol. Chem. 279 2004 6911 6920 (Pubitemid 38248834)
8. S. Hatziieremia, A.I. Gray, V.A. Ferro, A. Paul, and R. Plevin The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages Br. J. Pharmacol. 149 2006 188 198 (Pubitemid 44360100)
9. L.J. Ignarro Nitric oxide as a unique signaling molecule in the vascular system: a historical overview J. Physiol. Pharmacol. 53 2002 503 514 (Pubitemid 36014797)
10. H.W. Jeong, D.C. Han, K.H. Son, M.Y. Han, J.S. Lim, J.H. Ha, C.W. Lee, H.M. Kim, H.C. Kim, and B.M. Kwon Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase Biochem. Pharmacol. 65 2003 1343 1350 (Pubitemid 36407785)
11. B. Kaminska MAPK signalling pathways as molecular targets for anti-inflammatory therapy from molecular mechanisms to therapeutic benefits Biochim. Biophys. Acta 1754 2005 253 262 (Pubitemid 41797706)
12. T.H. Kang, E.I. Hwang, B.S. Yun, K.D. Park, B.M. Kwon, C.S. Shin, and S.U. Kim Inhibition of chitin synthases and antifungal activities by 2′-benzoyloxycinnamaldehyde from Pleuropterus ciliinervis and its derivatives Biol. Pharm. Bull. 30 2007 598 602 (Pubitemid 46355940)
13. S.A. Kim, Y.C. Kim, S.W. Kim, S.H. Lee, J.J. Min, S.G. Ahn, and J.H. Yoon Antitumor activity of novel indirubin derivatives in rat tumor model Clin. Cancer Res. 13 2007 253 259
14. S.A. Kim, Y.K. Sung, B.M. Kwon, J.H. Yoon, H. Lee, S.G. Ahn, and S.H. Hong 2′-Hydroxycinnamaldehyde shows antitumor activity against oral cancer in vitro and in vivo in a rat tumor model Anticancer Res. 30 2010 489 494
15. R. Korhonen, K. Linker, A. Pautz, U. Forstermann, E. Moilanen, and H. Kleinert Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase Mol. Pharmacol. 71 2007 1427 1434 (Pubitemid 46658695)
16. H.K. Kwon, J.S. Hwang, J.S. So, C.G. Lee, A. Sahoo, J.H. Ryu, W.K. Jeon, B.S. Ko, C.R. Im, S.H. Lee, Z.Y. Park, and S.H. Im Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1 BMC Cancer 10 2010 392
17. J.A. Kwon, C.B. Yu, and H.D. Park Bacteriocidal effects and inhibition of cell separation of cinnamic aldehyde on Bacillus cereus Lett. Appl. Microbiol. 37 2003 61 65 (Pubitemid 36783082)
18. B.M. Kwon, Y.K. Cho, S.H. Lee, J.Y. Nam, S.H. Bok, S.K. Chun, J.A. Kim, and I.R. Lee 2′-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia Planta Med. 62 1996 183 184
19. B.M. Kwon, S.H. Lee, S.U. Choi, S.H. Park, C.O. Lee, Y.K. Cho, N.D. Sung, and S.H. Bok Synthesis and in vitro cytotoxicity of cinnamaldehydes to human solid tumor cells Arch. Pharm. Res. 21 1998 147 152 (Pubitemid 128660988)
20. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 2001 807 869 (Pubitemid 32267078)
21. A. Lahti, U. Jalonen, H. Kankaanranta, and E. Moilanen c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages Mol. Pharmacol. 64 2003 308 315 (Pubitemid 36909994)
22. C.W. Lee, D.H. Hong, S.B. Han, S.H. Park, H.K. Kim, B.M. Kwon, and H.M. Kim Inhibition of human tumor growth by 2′-hydroxy- and 2′-benzoyloxycinnamaldehydes Planta Med. 65 1999 263 266 (Pubitemid 29186085)
23. H.S. Lee, and Y.J. Ahn Growth-inhibiting effects of Cinnamomum cassia bark-derived materials on human intestinal bacteria J. Agric. Food Chem. 46 1998 8 12
24. S.H. Lee, S.Y. Lee, D.J. Son, H. Lee, H.S. Yoo, S. Song, K.W. Oh, D.C. Han, B.M. Kwon, and J.T. Hong Inhibitory effect of 2′- hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-kappa B activation in RAW 264.7 cells Biochem. Pharmacol. 69 2005 791 799 (Pubitemid 40248621)
25. P. Libby, Y. Okamoto, V.Z. Rocha, and E. Folco Inflammation in atherosclerosis: transition from theory to practice Circ. J. 74 2010 213 220
26. M.W. Lin, L.T. Tsao, L.C. Chang, Y.L. Chen, L.J. Huang, S.C. Kuo, C.C. Tzeng, M.R. Lee, and J.P. Wang Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway Biochem. Pharmacol. 73 2007 1796 1806
27. N. McCartney-Francis, J.B. Allen, D.E. Mizel, J.E. Albina, Q.W. Xie, C.F. Nathan, and S.M. Wahl Suppression of arthritis by an inhibitor of nitric oxide synthase J. Exp. Med. 178 1993 749 754 (Pubitemid 23218226)
28. T. Michel, and O. Feron Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 100 1997 2146 2152
29. C. Szabó Alterations in nitric oxide production in various forms of circulatory shock New Horiz. 3 1995 2 32
30. T. Uto, M. Fujii, and D.X. Hou 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages Biochem. Pharmacol. 70 2005 1211 1221 (Pubitemid 41317515)
31. R.O. Wijesekera Historical overview of the cinnamon industry. CRC Crit. Rev. Food Sci. Nutr. 10 1978 1 30
32. K.J. Yun, J.Y. Kim, J.B. Kim, K.W. Lee, S.Y. Jeong, H.J. Park, H.J. Jung, Y.W. Cho, K. Yun, and K.T. Lee Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways Int. Immunopharmacol. 8 2008 431 441 (Pubitemid 351227435)
33. R. Zenz, R. Eferl, C. Scheinecker, K. Redlich, J. Smolen, H.B. Schonthaler, L. Kenner, E. Tschachler, and E.F. Wagner Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease Arthritis Res. Ther. 10 2008 201